The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation.

BACKGROUND & AIMS The hereditary hemochromatosis-associated membrane proteins HFE, TfR2, and HJV are required for adequate hepatic expression of the iron hormone hepcidin. While the genetic interactions are clear, it remains elusive how bone morphogenetic protein co-receptor HJV functions together with HFE and TfR2 to activate hepcidin transcription via the BMP-SMAD signaling pathway. Here, we investigate whether HFE, TfR2, and HJV physically interact on the surface of hepatocytes. METHODS We explore protein-protein interactions by glycerol gradient sedimentation assays and co-immunoprecipitation analyses in transfected HuH7 hepatoma-derived cells. RESULTS Our data demonstrate that HFE and TfR2 bind HJV in a non-competitive manner. Co-immunoprecipitation analyses provide direct experimental evidence that HFE, TfR2, and HJV form a multi-protein membrane complex. Our experiments show that like TfR2, HJV competes with TfR1 for binding to HFE, indicating that the expression of TfR2 and HJV may be critical for iron sensing. We identify residues 120-139 of the TfR2 extra-cellular domain as the critical amino acids required for the binding of both HFE and HJV. Interestingly, RGMA, a central nervous system homolog, can substitute for HJV in the complex and promote hepcidin transcription, implicating RGMA in the local control of hepcidin in the CNS. CONCLUSIONS Taken together, our findings provide a biochemical basis for hepcidin control by HFE, TfR2, and HJV.

[1]  S. Strittmatter,et al.  RGM and its receptor neogenin regulate neuronal survival , 2004, Nature Cell Biology.

[2]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[3]  W. Vogel,et al.  Altered hepatic BMP signaling pathway in human HFE hemochromatosis. , 2010, Blood cells, molecules & diseases.

[4]  C. Beaumont,et al.  Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. , 2009, Blood.

[5]  H. Tsukamoto,et al.  Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. , 2009, Cell metabolism.

[6]  Jerry Kaplan,et al.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.

[7]  N. Andrews,et al.  Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin. , 2010, Blood.

[8]  K. Jellinger,et al.  The Role of Iron in Neurodegeneration , 1999, Drugs & aging.

[9]  M. Roth,et al.  Lack of the bone morphogenetic protein BMP6 induces massive iron overload , 2009, Nature Genetics.

[10]  C. Enns,et al.  Diferric transferrin regulates transferrin receptor 2 protein stability. , 2004, Blood.

[11]  Matthias W. Hentze,et al.  Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.

[12]  C. Enns,et al.  HFE Modulates Transferrin Receptor 2 Levels in Hepatoma Cells via Interactions That Differ from Transferrin Receptor 1-HFE Interactions* , 2007, Journal of Biological Chemistry.

[13]  B. Bacon,et al.  Expression of iron-related genes in human brain and brain tumors , 2009, BMC Neuroscience.

[14]  Laura Marie Camus,et al.  Molecular Evolution of Hemojuvelin and the Repulsive Guidance Molecule Family , 2007, Journal of Molecular Evolution.

[15]  R. Wolff,et al.  The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression* , 1997, The Journal of Biological Chemistry.

[16]  M. Roth,et al.  BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. , 2009, Blood.

[17]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[18]  N. Andrews,et al.  The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. , 2008, Cell metabolism.

[19]  Paolo Ventura,et al.  Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. , 2009, Gastroenterology.

[20]  K. Finberg Iron-refractory iron deficiency anemia. , 2009, Seminars in hematology.

[21]  M. Fleming,et al.  Transgenic HFE‐dependent induction of hepcidin in mice does not require transferrin receptor‐2 , 2012, American journal of hematology.

[22]  Raymond T Chung,et al.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.

[23]  Matthias W. Hentze,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004 .

[24]  L. Weiner,et al.  Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. , 2001, Journal of molecular biology.

[25]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[26]  D. Purdie,et al.  Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis , 2003, The Lancet.

[27]  N. Andrews,et al.  Expression of stimulator of Fe transport is not enhanced in Hfe knockout mice. , 2001, The Journal of nutrition.

[28]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[29]  A. West,et al.  The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. , 1999, Journal of molecular biology.

[30]  D. Berg,et al.  The basal ganglia in haemochromatosis , 2000, Neuroradiology.

[31]  Paige S. Davies,et al.  Mechanisms of HFE-induced regulation of iron homeostasis: Insights from the W81A HFE mutation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Erfle,et al.  Identification of cholesterol-regulating genes by targeted RNAi screening. , 2009, Cell metabolism.

[33]  A. Pietrangelo,et al.  Huh‐7: A human “hemochromatotic” cell line , 2010, Hepatology.

[34]  M. Hentze,et al.  Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis , 2003, Nature Genetics.

[35]  G. Anderson,et al.  Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload , 2009, Hepatology.

[36]  Peter Schulz-Knappe,et al.  LEAP‐1, a novel highly disulfide‐bonded human peptide, exhibits antimicrobial activity , 2000, FEBS letters.

[37]  O. von Bohlen und Halbach,et al.  Distribution of the iron‐regulating protein hepcidin in the murine central nervous system , 2006, Journal of neuroscience research.

[38]  Thomas Walz,et al.  Structure of the Human Transferrin Receptor-Transferrin Complex , 2004, Cell.

[39]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.

[40]  N. Andrews,et al.  Comparison of the Interactions of Transferrin Receptor and Transferrin Receptor 2 with Transferrin and the Hereditary Hemochromatosis Protein HFE* , 2000, The Journal of Biological Chemistry.

[41]  D. M. Penny,et al.  The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Bjorkman,et al.  Crystal Structure of the Hemochromatosis Protein HFE and Characterization of Its Interaction with Transferrin Receptor , 1998, Cell.

[43]  N. Andrews,et al.  Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis , 2003, Nature Genetics.

[44]  Marie-Pierre Dubé,et al.  Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis , 2004, Nature Genetics.

[45]  K. Nicholas,et al.  GeneDoc: Analysis and visualization of genetic variation , 1997 .

[46]  S. Kölker,et al.  Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. , 2011, Brain : a journal of neurology.

[47]  C. Woolf,et al.  Repulsive Guidance Molecule (RGMa), a DRAGON Homologue, Is a Bone Morphogenetic Protein Co-receptor* , 2005, Journal of Biological Chemistry.

[48]  V. Beneš,et al.  The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. , 2011, The Journal of clinical investigation.

[49]  N. Andrews,et al.  Hereditary Hemochromatosis Protein, HFE, Interaction with Transferrin Receptor 2 Suggests a Molecular Mechanism for Mammalian Iron Sensing* , 2006, Journal of Biological Chemistry.

[50]  T. Montine,et al.  Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[51]  K. Krabbe,et al.  Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[52]  H. Koeffler,et al.  Regulation of expression of murine transferrin receptor 2. , 2001, Blood.

[53]  Paolo Gasparini,et al.  The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 , 2000, Nature Genetics.

[54]  Yin Xia,et al.  BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism , 2009, Nature Genetics.

[55]  J. Crowe,et al.  Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis , 2010, Hepatology.

[56]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[57]  M. Wessling-Resnick,et al.  Regulation of transferrin receptor 2 protein levels by transferrin. , 2004, Blood.